Active Surveillance for Localized Prostate Cancer

Active Surveillance for Localized Prostate Cancer

A New Paradigm for Clinical Management

Klotz, Laurence

Birkhauser Verlag AG






15 a 20 dias

Descrição não disponível.
Table of Contents Chapter 1 Cancer Overdiagnosis and Overtreatment Laurence Klotz Chapter 2 Can We Screen and Still Reduce Overdiagnosis? Peter Ka-Fung Chiu and Monique J. Roobol Chapter 3 The Role of Fear in Overdiagnosis and Overtreatment Iona Heath Chapter 4 Ethical and Legal Considerations in Active Surveillance for Prostate Cancer Lionne D.F. Venderbos Chapter 5 Gleason 6 Tumors Should Still Be Labeled As Cancer Angelo M. De Marzo and Jonathan I. Epstein Chapter 6 Risk Based Selection for Active Surveillance Jan F.M. Verbeek, Monique J. Roobol and Ewout W. Steyerberg Chapter 7 Surveillance at the Margins: Management of High Volume Gleason 6, PSA > 10, or Gleason 3+4 Laurence Klotz Chapter 8 How Should Patients on Active Surveillance be Followed? Frank-Jan H. Drost, Monique J. Roobol, and Leonard P. Bokhorst Chapter 9 Triggers for Intervention Tuomas Mirtti, Hanna Vasarainen, and Antti Rannikko Chapter 10 MR Imaging in Prostate Tumor Volume Assessment: How Accurate? Ivo G. Schoots and Theo H. van der Kwast Chapter 11 Can MRI Replace Biopsy in Men on Surveillance? Francesco Giganti, Vasilis Stavrinides, and Caroline M. Moore Chapter 12 Tissue Based Markers for Risk Prediction Chad A. Reichard and Eric A. Klein Chapter 13 International AS Registry: The Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative Sophie M. Bruinsma, Daan Nieboer, Tim Hulsen, Liying Zhang, Rachelle Kirk- Burnnand, Sam Gledhill, and Mark Buzza on behalf of the Movember Foundation's GAP3 Steering Committee Chapter 14 Better Informed Decision Making to Optimize Patient Selection Lara Bellardita, Paola Dordoni, Letizia De Luca, Julia Paola Menichetti Delor, Riccardo Valdagni Chapter 15 How Does QOL Compare Between Surveillance and Active Treatment? Lionne D.F. Venderbos, Stephanie Danielle Brandhof, and Ida J. Korfage Chapter 16 The Potential Benefits of Diet and Physical Activity among Active Surveillance Patients with Low-Burden Prostate Cancer Stacey A. Kenfield, David Tat, and June M. Chan Chapter 17 Is there a Role for Pharmacologic Manipulation to Prevent Progression in Men on Active Surveillance? The Role of 5-ARIs, Statins, and Metformin Roy Mano and David Margel Chapter 18 The Update of Active Surveillance around the World: Utilization and Outcomes Jeffrey J. Tosoian, Ridwan Alam, Abbey Lepor, Stacy Loeb Chapter 19 Tissue Preservation - Active Surveillance and Focal Therapy as Complimentary Strategies Juan Gomez Rivas and Mark Emberton Chapter 20 The Economics of Active Surveillance for Prostate Cancer Robert B. Lurvey and Marc A. Dall'Era Chapter 21 Research Questions in Active Surveillance Laurence Klotz
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.